glp 1 mitochondria JCI The Role of Glucagon-Like Peptide-1

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

Watch now (61 mins) | Sabina Hemmi: What the latest legislature could mean for compounded GLP-1 medications

Discover how employers are reducing GLP-1 costs while improving outcomes

The prescribing of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surged for the treatment of diabetes and obesity, with more than 15 million users worldwide

But now that the shortage is...